| Income Statement | 2024-09-30 | |||
|---|---|---|---|---|
| Revenue from contract with customer, excluding assessed tax, total | 1,985 | |||
| Selling, general and administrative expense | 5,378 | |||
| Research and development expense | 2,667 | |||
| Cost of goods and services sold | 4,101 | |||
| Costs and expenses | 12,146 | |||
| Operating income (loss) | -10,161 | |||
| Other, net | 16 | |||
| Change in fair value of derivative warrant liability | 321 | |||
| Change in fair value of derivative related to term loan with related party | 77 | |||
| Interest expense to related party | 370 | |||
| Total other income (expense) | 44 | |||
| Net loss | -10,117 | |||
| Basic eps | -0.57 | |||
| Diluted eps | -0.57 | |||
| Basic average shares | 17,892,606 | |||
| Diluted average shares | 17,892,606 | |||
T2 Biosystems, Inc. (TTOO)
T2 Biosystems, Inc. (TTOO)